Colloid preparations are plasma expanders containing oncotic macromolecules (MW >35 kDa), usually albumin, gelatin, starch or dextran 1 . Although less fluid than saline is required for equivalent volume expansion 2 , colloid infusions can trigger a similar metabolic acidosis 3-7 . As with saline 8-13 , this may be undesirable. However, there are questions concerning the exact mechanism(s) and severity compared with saline-induced acidosis, and whether certain colloids are more prone to this complication.
The situation with colloids is more complex. Since albumin and gelatin are weak acids, their infusion introduces A TOT into the intravascular compartment. At the same time there are variable SID increases above zero in their electrolyte vehicles. For example, Albumex 4 (CSL, Parkville, Vic.), Gelofusine (B. Braun, Bella Vista, nSW) and Haemaccel (DeltaSelect GmbH, Dreieich, Germany) are all saline-based weak acid colloid preparations, containing 4% human albumin, 4% succinylated gelatin and 3.5% polygeline respectively (Table 1 ). In each case the saline vehicle has been modified, partly but not solely for pH adjustment, increasing SID values above the unmodified saline value of zero.
With Albumex 4, just over half of the SID of 12 mEq/l can be attributed to the addition of sodium octanoate, which acts as a stabiliser during pasteurisation, while NaOH accounts for the remainder (personal communication, Joseph Bertolini, CSl Bioplasma, Broadmeadows, Vic.), bringing the final pH to 6.7 to 7.3. Each 500 ml of Gelofusine contains 680 mg of NaOH, increasing the SID to 34 mEq/l, and the pH to 7.1 to 7.7. In the case of Haemaccel, the electrolyte vehicle is essentially saline supplemented with kOH and Ca (OH) 2 , boosting the SID to 17.6 mEq/l, and the final pH to 7.0 to 7.6.
An increased SID retards the fall in extracellular SID on infusion of these colloids compared with saline infusion, lessening the SID reduction stimulus towards metabolic acidosis. Conversely, infusion of A TOT reduces or eliminates the A TOT dilution metabolic alkalosis induced by crystalloid infusions.
The net result is still metabolic acidosis, judging by available reports [3] [4] [5] [6] [7] .
The two remaining colloids, starch and dextran, are not acids. like saline, their preparations contain zero A TOT . Not needing significant pH adjustment, the SID of their standard vehicles, usually saline, is likely to be zero; for example the 6% hetastarch preparation in Table 1 . Consequently, a saline-type acidosis can be expected following large volume administration 3, 6 . Thus many colloid preparations, weak acid or otherwise, tend to induce a metabolic acidosis after trade-offs between weak acid activity and SID adjustment of their electrolyte vehicles.
At the time of writing, the acid-base effects of different colloids have not been compared, nor the relative weak acid strengths of succinylated gelatin, urea-linked gelatin (polygeline) and albumin. One way to quantify gelatin weak acid properties is to infuse a given volume of fluid and track the unmeasured weak acid anion concentration via the strong ion gap (SIG) 24, 25 . The SIG is superior to the anion gap for this purpose, since it retains sensitivity to unmeasured anions despite fluctuating albumin and phosphate concentrations, simply because the Acomponents of albumin and phosphate are intrinsic to the SIG calculation 26 . However, by the same token the SIG cannot be used to track the weak acid contribution of infused albumin.
We therefore evaluated the effects of four widelyused colloid preparations versus saline on SIG and on overall acid-base balance during ex vivo haemodilution. Each colloid contained a different macromolecule. The dextrans were not assessed, since large volumes are generally avoided because of adverse effects 1 .
MATErIAlS AnD METHODS
The experimental protocol was approved by the Mater Health Services Human Research Ethics Committee. We used ex vivo haemodilution to model volume resuscitation of an acute 50% blood loss, adapting methodology from a previous crystalloid experiment 20 . Serial dilutions of fresh venous blood were performed using the five fluids in Table 1 . Each specimen was subjected to a four step dilution sequence, starting with a diluent to blood ratio of 1:5 vol:vol, and culminating in a ratio of 1:1.
Four hypotheses were tested:
That haemodilution with each of the four colloid 1.
preparations reduces whole blood base excess (BE). That BE reductions are similar to that produced 2.
by an equivalent saline haemodilution.
That haemodilution with 4% succinylated gelatin 3. and 3.5% polygeline increases the SIG, due to the weak acid activity of gelatin.
That haemodilution with saline, 4% albumin 4. and 6% hetastarch does not increase the SIG.
Venous blood was collected from four of the investigators (TJM, DMC, SLW, BV), each specimen consisting of 35 ml drawn into a 50 ml syringe containing 100 units of sodium heparin. Specimens were gently agitated with air until the haemoglobin saturation (SO 2 ) exceeded 95% on preliminary blood gas and electrolyte analysis (ABl 800, radiometer, Copenhagen, Denmark). At this point 2 ml were placed in a lithium heparin tube (Vacutainer, Becton Dickinson, north ryde, nSW) for later multi-channel analysis, and five 5 ml aliquots were drawn from the remainder into separate 10 ml syringes. These were connected to three-way taps, sealed with rubber stoppers and placed on ice awaiting haemodilution.
Each of the five fluids under study ( Table 1) was drawn into a separate labelled 5 ml syringe and allocated to one blood syringe. Each blood specimen then underwent four sequential dilutions with the allocated fluid via the three-way tap. Mixing was ensured on every occasion by slow reciprocation to and from a clean syringe for two minutes. Blood gas and electrolyte analyses were performed before and after dilutions. No attempt was made to control specimen temperatures during this time, although all analyser measurements were at 37°C. Diluent volumes were 1 ml for the first three dilutions. This was increased to 2 ml for the final dilution, making a total diluent volume of 5 ml per specimen. On completion, 2 ml of residual diluted blood from each fluid group was sent for multi-channel biochemical analysis, along with the pre-dilution sample common to all groups.
Measurements
recorded blood gas and electrolyte data included total haemoglobin concentration ([Hb]) and SO 2 (both from the co-oximeter output), plus plasma pH, PCO 
Data analysis
Analysis was performed using SAS version 9.1 for Windows. Analysis of variance was used to compare change from baseline in dependent variables. Scheffe's method of multiple comparisons was used to further compare group effects. For the BE outcome a linear mixed regression model was used to compare time trends between groups.
Unless otherwise specified, data are presented as mean (SD). P values <0.05 were considered significant. 
RESULTS
The results are set out in Tables 2 and 3 and in  Figures 1 to 3 . Baseline data, common to all groups, confirmed normal initial metabolic acid-base status ( Table 2) . Following final haemodilution, all [Hb] values fell by around 50% (Table 3 ). SO 2 exceeded 95% throughout, minimising the altered buffering contribution of de-oxyhaemoglobin 29 .
Each dilution sequence triggered a progressive reduction in BE (Figures 1 and 2) . All BE/[Hb] relationships were linear, closely resembling that figure 3: Strong ion gap (SIG) values pre and post dilution. Predilution values were common to all fluid groups. Post-dilution values separated into three discrete clusters. Small increases were seen with 0.9% saline, 4% albumin and 6% hetastarch (HES). Moderate increases followed dilution with 3.5% polygeline. The largest increases followed dilution with 4% succinylated gelatin.
of saline. Slopes and intercepts were statistically indistinguishable (Figure 1 , P >0.5). Final BE values for each fluid showed significant but uniform reductions from baseline ( Table 2) . By contrast, the SIDa sequences of all colloids except 6% hetastarch diverged progressively from that of saline (Figure 2 ). There were also significant changes in several individual electrolytes, especially [Cl -]. Many of these post-dilution changes differed significantly across groups (Tables 2 and 3 ). In each group [albumin] was significantly reduced, although less so after 4% albumin dilution. All [phosphate] reductions were uniform.
Final SIG values increased significantly with all fluids ( Table 2 ). Increases occurred in three distinct clusters ( Figure 3 ): large (4% succinylated gelatin), intermediate (3.5% polygeline) and small (6% hetastarch, 0.9% saline and 4% albumin).
DISCUSSION
Our main finding was that the four colloid preparations caused a progressive metabolic acidosis indistinguishable in rate of progression and ultimate severity from that induced by saline. BE/[Hb] relationships were linear and direct, as found previously with crystalloid haemodilution 20 . BE/[Hb] sequences for the four colloids and saline were virtually superimposed in the blood of each individual (Figure 2) .
Bicarbonate reductions were also similar. However, ascribing the acidosis to simple 'bicarbonate dilution' is misleading. To expose this conceptual flaw, it is sufficient to note that bicarbonate concentrations could have been clamped (or even increased) at each stage of the dilution process, without altering the rate of onset or severity of the metabolic acidosis. All that was required was a progressive increase in ambient PCO 2 at each step. At a final PCO 2 of around 250 mmHg, final bicarbonate concentrations would have been similar to pre-dilution concentrations. With higher ambient CO 2 tensions, they would have increased.
The SIG responses were revealing. Sizeable increases after 4% succinylated gelatin and 3.5% polygeline dilution confirmed that both have considerable weak acid activity. Of note, the increase after 4% succinylated gelatin was almost double that caused by 3.5% polygeline. Ionised magnesium measurements, ideally part of the SIG calculations, were unavailable. We accepted small reductions in SIG values (including some negative baseline values) in preference to estimating ionised magnesium from total concentrations. Because all colloids produced uniform BE reductions, it was possible to make a qualitative comparison of the weak acid strengths of albumin and the two gelatins. Plasma SIDa reductions caused by 3.5% polygeline were similar to those of 4% albumin, whereas reductions caused by 4% succinylated gelatin were smaller (Table 1, Figure 2 ). To achieve equivalent falls in BE, both gelatins must have delivered more weak acid (A TOT ) per gram than albumin, with succinylated gelatin the greatest contributor. Hence the sequence, in decreasing order of weak acid activity, is succinylated gelatin, followed by polygeline, followed by albumin.
Small SIG increases seen after haemodilution with 0.9% saline, 4% albumin and 6% hetastarch were unexpected, since saline and hetastarch have no intrinsic weak acid activity, while the albumin anionic component is incorporated in the SIG calculation. We speculate that these reflect Krebs cycle anions [30] [31] [32] , generated by leukocyte mitochondria during the stress of ex vivo storage and haemodilution.
There are less plausible possibilities. SIG algorithm susceptibility to pH or albumin fluctuations seems unlikely, in view of a recent searching in vitro evaluation 26 . Infused octanoate accompanying albumin dilution fails to explain similar SIG increases after saline and hetastarch. Other potential but unlikely confounders include bias introduced by albumin immunoassay, or systematic measurement offsets in chloride or other analytes.
We conclude that the four colloids tested, consisting of two gelatin-based fluids, another containing hydroxyethyl starch and another based on albumin, each cause a metabolic acidosis of near identical severity to that caused by saline on ex vivo haemodilution, despite weak acid (A TOT ) activity ranging from zero with hydroxyethyl starch to well above that of albumin with succinylated gelatin. The physical chemical explanation is that potential deviations from the saline acid-base properties of the electrolyte vehicles due to colloid weak acid activity have been countered by proportional SID increases.
Future studies should repeat the exercise in vivo, in models such as normovolaemic haemodilution and hypovolaemic resuscitation. The added complexities of in vivo equilibration prevent direct extrapolation of our ex vivo findings. One important difference is that introduced colloid is confined to the intravascular compartment for a variable time period 1 , whereas infused strong ions can distribute across fluid compartments from the outset, as governed by electrical and chemical gradients, Gibbs Donnan forces and membrane pump activity. Trans-membrane water shifts also play a potentially greater role, simultaneously increasing the SID in the compartment of origin and decreasing the SID in the destination compartment.
Finally, with balanced hetastarch preparations already under evaluation 9, 33, 34 , there is a need for electrolyte vehicles balanced for the weak acids albumin and gelatin. To balance weak acid preparations, further proportional SID increases in their electrolyte vehicles are necessary to counter their A TOT properties. Hence, the requisite SID will vary in each case, but should always exceed the balanced value for crystalloids (24 mEq/l) [20] [21] [22] [23] 35 . In a 4% albumin preparation, the balanced SID should approximate that of normal plasma (around 40 mEq/l), whereas higher SID values will be necessary for polygeline and succinylated gelatin preparations. In any event, each vehicle should be designed and tested using methodology based on physical chemistry. rEFErEnCES
